Use of bacille Calmette-Guérin in superficial bladder cancer. - Wikidata - wikimedia - TriplyDB

Use of bacille Calmette-Guérin in superficial bladder cancer.

Use of bacille Calmette-Guérin in superficial bladder cancer.

http://www.wikidata.org/entity/Q34788204

about

Targeting Hsp90 in urothelial carcinoma Immunotherapy in genitourinary malignancies.Mathematical model of tumor immunotherapy for bladder carcinoma identifies the limitations of the innate immune response Ruptured aortic aneurysm due to Mycobacterium bovis BCG with a delayed bacteriological diagnosis due to false negative result of the MPB 64 immunochromatographic assay Granulomas of the penis: a rare complication of intravesical therapy with Bacillus Calmette-Guerin.Immunotherapeutic approaches for cancer therapy: An updated review.Challenges to Improve the Stability and Efficacy of an Intravesical BCG Product.Tackling non-muscle invasive bladder cancer in the clinic.Bacille Calmette-Guérin intravesical instillation and erectile function: is there a concern?Impulsive control dosing BCG immunotherapy for non-muscle invasive bladder cancer

P2860

Q27023406-9B886C40-8F6A-4559-80E9-F609510E5277 Q33593800-7BE3CF2F-75BB-48B2-8C7B-516BF3EB1684 Q36038379-704F4BA3-C404-4D9D-BCF1-D00F47950109 Q36261760-EBCF9532-21E7-46A3-8DF2-30360CEAD10C Q37944174-E3A421F1-263A-4A73-BA7B-780D7EC39214 Q38388102-C3AADAB6-29E9-4C80-B802-9042C90085FE Q38627969-0B6D9EFF-BDBF-472D-A409-24C3C9DFB6B2 Q39209020-4ADF2FF8-992A-4019-AF0D-530F317C157E Q53238563-679C2102-38EA-44CE-A31B-123C10C6F73A Q58196020-510DD725-8154-454F-A51D-31CE49EE9B8F

P2860

Use of bacille Calmette-Guérin in superficial bladder cancer.

http://www.wikidata.org/entity/Q34788204

description

2002 nî lūn-bûn

@nan

2002 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年学术文章

@wuu

2002年学术文章

@zh-cn

2002年学术文章

@zh-hans

2002年学术文章

@zh-my

2002年学术文章

@zh-sg

2002年學術文章

@yue

name

Use of bacille Calmette-Guérin in superficial bladder cancer.

@ast

Use of bacille Calmette-Guérin in superficial bladder cancer.

@en

Use of bacille Calmette-Guérin in superficial bladder cancer.

@nl

type

label

Use of bacille Calmette-Guérin in superficial bladder cancer.

@ast

Use of bacille Calmette-Guérin in superficial bladder cancer.

@en

Use of bacille Calmette-Guérin in superficial bladder cancer.

@nl

prefLabel

Use of bacille Calmette-Guérin in superficial bladder cancer.

@ast

Use of bacille Calmette-Guérin in superficial bladder cancer.

@en

Use of bacille Calmette-Guérin in superficial bladder cancer.

@nl

P1433

Q34788204-00762B5C-FF79-4C73-A25B-4486D3CDCA62

P1476

Q34788204-DB24B4CF-59A4-4273-A866-6D42A8DA53A7

P2093

Q34788204-3FDED0C2-F98D-4DD2-8B8B-9AE4DE4EBD5D

Q34788204-A1589157-F591-461D-98C0-3527E5CD192F

Q34788204-A39634E6-6E6C-4E07-8028-31CA806E5698

P2860

Q34788204-05E697CF-F7D8-4181-9460-B332753F7132

Q34788204-12C9C5C7-E653-469D-88E2-F5958A6D4ECA

Q34788204-53CB65A9-DFA4-4B1C-ADD1-377EF0FDBC51

Q34788204-618B94E8-68D6-448C-929A-17B9FF36FE18

Q34788204-779BB6E6-FE46-4B43-8FDE-33FD6E5C5CFE

Q34788204-77E324A8-0B92-4F8C-A4F7-CDDF3D7C97DB

Q34788204-7BB1615D-9FE0-4D8A-961A-12AD9E161193

Q34788204-894E7B9C-DB6F-450B-B45D-C926C2C5AB3E

Q34788204-8C5449C3-49D5-42B9-996E-F98CF30A1F4D

Q34788204-A5564320-A0E0-4322-8C94-48049469D115

P304

Q34788204-DC7DF795-ADD1-4E7C-8A76-59A5CEF6EFC2

P31

Q34788204-A6C3A0A6-80C4-4BF9-B643-F0908FA239D7

P356

Q34788204-C305683A-444A-4056-95BB-C3EDBE611080

P407

Q34788204-EDEEA2F1-476C-414C-B641-5C66FB13BA42

P433

Q34788204-D9DF9E5B-093F-41C2-92F0-E7573A8387A1

P478

Q34788204-E1CF9B9E-899D-48E4-91A5-A0C4826FA025

P577

Q34788204-4B7372F4-1891-48D7-9746-BD0371054476

P5875

Q34788204-AE137C83-8CF9-49AB-9DD8-D08565AB8F4E

P698

Q34788204-62D9D19E-A475-4607-B073-190964F15C45

P932

Q34788204-C25FA886-51A7-4914-8F22-A15226ED438D

P356

P1433

Postgraduate Medical Journal

P1476

Use of bacille Calmette-Guérin in superficial bladder cancer.

@en

P2093

Gillatt DA

http://www.w3.org/2001/XMLSchema#string

Meyer JP

http://www.w3.org/2001/XMLSchema#string

Persad R

http://www.w3.org/2001/XMLSchema#string

P2860

BCG intravesical instillations: recommendations for side-effects management.

Multivariate analysis of the prognostic factors of primary superficial bladder cancer.

The management of superficial bladder cancer.

A randomized trial of intravesical doxorubicin and immunotherapy with bacille Calmette-Guérin for transitional-cell carcinoma of the bladder.

Long-term results of intravesical therapy for superficial bladder cancer.

Induction of ICAM 1 expression on bladder tumours by BCG immunotherapy.

Incidence and treatment of complications of bacillus Calmette-Guerin intravesical therapy in superficial bladder cancer.

A low dose bacillus Calmette-Guerin regimen in superficial bladder cancer therapy: is it effective?

Bacillus Calmette-Guerin immunotherapy of superficial bladder cancer.

Murine bladder carcinoma cells present antigen to BCG-specific CD4+ T-cells.

P304

449-454

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/PMJ.78.922.449

http://www.w3.org/2001/XMLSchema#string

P407

P433

922

http://www.w3.org/2001/XMLSchema#string

P478

78

http://www.w3.org/2001/XMLSchema#string

P577

2002-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11202692

http://www.w3.org/2001/XMLSchema#string

P698

12185215

http://www.w3.org/2001/XMLSchema#string

P932

1742458

http://www.w3.org/2001/XMLSchema#string